%0 Journal Article
%T 子宫腺肌病临床研究进展<br>Clinical Research Progress of Adenomyosis
%A 席欣欣
%A 张林凤
%A 李佳
%J Advances in Clinical Medicine
%P 11852-11857
%@ 2161-8720
%D 2022
%I Hans Publishing
%R 10.12677/ACM.2022.12121707
%X 子宫腺肌病(Adenomyosis, AM)是指在子宫肌层中存在子宫内膜组织，并伴有不等程度的肌层平滑肌细胞肥大和增生。AM是一种常见且难治的妇科良性肿瘤性疾病，是导致育龄期女性及围绝经期女性子宫全切的主要原因之一。近年来，生育力保护的理念得到了人们的认可。女性越来越关注子宫的生殖健康，要求子宫腺肌病的治疗长效化。然而，目前AM的发病机制尚不明确。<br />
Adenomyosis (AM) refers to the presence of endometrial tissue in the myometrium, accompanied by varying degrees of hypertrophy and proliferation of myometrial smooth muscle cells. AM is a common and refractory gynecological benign tumor disease, which is one of the main reasons for total hysterectomy in women of childbearing age and perimenopause. In recent years, the concept of fertility protection has been recognized by people. Women pay more and more attention to the reproductive health of the uterus and require long-term treatment of adenomyosis. However, the pathogenesis of AM is still unclear.
%K 子宫腺肌病，发病机制，治疗<br>Adenomyosis
%K Pathogenesis
%K Treatment
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=59671